Staidson (Beijing) BioPharmaceuticals Co., Ltd. (SHE:300204)
China · Delayed Price · Currency is CNY 19.68
-0.44 (-2.19%)
Sep 11, 2026, 3:04 PM CST
SHE:300204 Market Cap
SHE:300204 has a market cap or net worth of 9.4 billion as of September 11, 2026. Its market cap has decreased by -46.84% in one year.
Market Cap
9.40B
Enterprise Value
9.42B
Revenue
187.53M
Ranking
n/a
PE Ratio
n/a
Stock Price
19.68
ChartMarket Cap Chart
Since April 15, 2011, SHE:300204's market cap has increased from 3.33B to 9.40B, an increase of 182.59%. That is a compound annual growth rate of 6.97%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 9.40B | -27.96% |
| Dec 31, 2025 | 13.05B | 268.69% |
| Dec 31, 2024 | 3.54B | -27.07% |
| Dec 29, 2023 | 4.85B | -24.38% |
| Dec 30, 2022 | 6.42B | -22.12% |
| Dec 31, 2021 | 8.24B | 94.35% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Chengzhi | 11.50B |
| Inner Mongolia Furui Medical Science | 11.46B |
| Tibet Cheezheng Tibetan Medicine | 11.46B |
| InventisBio | 11.36B |
| Mabwell (Shanghai) Bioscience | 11.20B |
| Hualan Biological Vaccine | 10.81B |
| Jiangxi Fushine Pharmaceutical | 10.75B |
| Nanjing Vazyme Biotech | 10.55B |